What does really make a company so special and extraordinary???
Without any doubt special and extraordinary people,like Steve Jobs, Elon Musk, Bill Gates, Jack Ma, and...
What makes ADITX special is the story behind this company which started almost 40 years ago. If you check the founders of the company on TradingView, you will see the names of Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna.
I would like to write about Leonard L. Bailey, and his incredible story. Leonard Lee Bailey (1942–2019) was an American surgeon who garnered international media attention in 1984 for transplanting a baboon’s heart into a human infant.
In 1984, in a desperate attempt to save the life of a baby girl, Dr. Bailey performed the first cross-species infant heart transplant. Born three weeks early, Stephanie Fae (known as Baby Fae) was diagnosed with 100% lethal hypoplastic left heart syndrome.
Dr. Bailey, having seen too many newborns succumb to this condition, was prepared. For years, he had been performing research through experimental transplantation in sheep, goats and baboons. By the time Baby Fae was born, he had performed over 200 of these procedures.
With no time and no other options, Dr. Bailey did what he knew he had to — what he knew could save this girl’s life. As media members and animal rights activists gathered outside the building, Bailey and the medical staff focused all their energy on the little girl. Baby Fae survived the transplant, which provided her a new, healthy and, against all odds, beating baboon heart.
Though the transplant gave her a little extra time, Baby Fae tragically passed away 21 days later. She became the longest-living recipient of a cross-species heart.
The next year, in 1985, Dr. Bailey once again met a patient in need of a new heart. This time, though, a suitable donor heart was available. Using the lessons he learned with Baby Fae, Dr. Bailey performed the first successful human-to-human heart transplant on an infant. Little Eddie Anguiano (known as Baby Moses) not only survived, but continues to thrive to this day at 35 years old. Eddie is the longest-living recipient of an infant heart transplant — that same heart still beats in his chest.(Loma Linda university website)
What he did 37 years ago looks like Sci-fi movies today..!
But what makes ADITX special doesn’t end here, ADITX starts generating revenue through its contract with Todos medical just 7 months after its IPO in July 30th 2020, which is very unusual for a biotechnology company. Usually, biotechnology companies tend to burning cash for many years before generating any revenue..! Yet it’s a normal, because developing a medical product and getting all the FDA approvals is a long process.
I will not be shocked if soon Cathie Wood (ARK Invest) talks about this company and buy its stocks, because what ADITX is doing is in the field of their interest “Genomic field”..! Ark invest actually count heavily on genomic fields for the next decade..!
Having reviewed this incredible story, I will review the technical reasons that I put this in my recommended portfolio in a video soon..!
Stay tuned great live stream and quality content videos coming soon..!
Don't forget to like, comment, and Follow to encourage me to continue this.
You can even send TradingView coins to support me publishing high quality ideas..!
Without any doubt special and extraordinary people,like Steve Jobs, Elon Musk, Bill Gates, Jack Ma, and...
What makes ADITX special is the story behind this company which started almost 40 years ago. If you check the founders of the company on TradingView, you will see the names of Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna.
I would like to write about Leonard L. Bailey, and his incredible story. Leonard Lee Bailey (1942–2019) was an American surgeon who garnered international media attention in 1984 for transplanting a baboon’s heart into a human infant.
In 1984, in a desperate attempt to save the life of a baby girl, Dr. Bailey performed the first cross-species infant heart transplant. Born three weeks early, Stephanie Fae (known as Baby Fae) was diagnosed with 100% lethal hypoplastic left heart syndrome.
Dr. Bailey, having seen too many newborns succumb to this condition, was prepared. For years, he had been performing research through experimental transplantation in sheep, goats and baboons. By the time Baby Fae was born, he had performed over 200 of these procedures.
With no time and no other options, Dr. Bailey did what he knew he had to — what he knew could save this girl’s life. As media members and animal rights activists gathered outside the building, Bailey and the medical staff focused all their energy on the little girl. Baby Fae survived the transplant, which provided her a new, healthy and, against all odds, beating baboon heart.
Though the transplant gave her a little extra time, Baby Fae tragically passed away 21 days later. She became the longest-living recipient of a cross-species heart.
The next year, in 1985, Dr. Bailey once again met a patient in need of a new heart. This time, though, a suitable donor heart was available. Using the lessons he learned with Baby Fae, Dr. Bailey performed the first successful human-to-human heart transplant on an infant. Little Eddie Anguiano (known as Baby Moses) not only survived, but continues to thrive to this day at 35 years old. Eddie is the longest-living recipient of an infant heart transplant — that same heart still beats in his chest.(Loma Linda university website)
What he did 37 years ago looks like Sci-fi movies today..!
But what makes ADITX special doesn’t end here, ADITX starts generating revenue through its contract with Todos medical just 7 months after its IPO in July 30th 2020, which is very unusual for a biotechnology company. Usually, biotechnology companies tend to burning cash for many years before generating any revenue..! Yet it’s a normal, because developing a medical product and getting all the FDA approvals is a long process.
I will not be shocked if soon Cathie Wood (ARK Invest) talks about this company and buy its stocks, because what ADITX is doing is in the field of their interest “Genomic field”..! Ark invest actually count heavily on genomic fields for the next decade..!
Having reviewed this incredible story, I will review the technical reasons that I put this in my recommended portfolio in a video soon..!
Stay tuned great live stream and quality content videos coming soon..!
Don't forget to like, comment, and Follow to encourage me to continue this.
You can even send TradingView coins to support me publishing high quality ideas..!
